Compugen Ltd (CGEN) stock
CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30
$2.04−0.06 (-2.86%)
Close on Nov 16, 2026Market cap $192.89MP/E 5.4Yield –
Compugen EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Compugen's EV/EBITDA was 4.7× on Nov 11, 2026.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.7× | – |
See a number that looks wrong?